{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:05:11Z","timestamp":1791234311558,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD), driven by obesity and metabolic syndrome, is increasingly prevalent and a significant contributor to liver fibrosis, cirrhosis, and liver-related mortality. Emerging research implicates the gut microbiome as a critical player in MASLD progression, yet specific microbial drivers remain poorly understood. Here, we explore the role of Prevotella copri (P. copri) in MASLD progression through both human patient cohorts and a mouse model of diet-induced obesity. Methods\/Results: Using 16S rRNA sequencing, we identified elevated P. copri abundance in MASLD patients with advanced fibrosis, linked with significant shifts in microbial diversity and bacterial network connectivity. To investigate causality, experimental colonization of P. copri in mice on a high-fat diet worsened MASLD progression, with P. copri-colonized mice showing significant increases in hepatic steatosis, liver triglyceride accumulation, and body weight, independent of caloric intake. At the molecular level, P. copri colonization downregulated key lipid metabolism genes, such as carnitine palmitoyltransferase 1 and adipose triglyceride lipase, and impaired tight intestinal junction integrity through the downregulation of occludin. Collectively, our findings position P. copri as a possible driver of MASLD progression by promoting hepatic steatosis through lipid and triglyceride accumulation and fibrosis through decreased tight junction integrity. These insights suggest a promising therapeutic avenue to target specific microbial signatures like P. copri to curb MASLD progression and mitigate the associated risk of advanced fibrosis.<\/jats:p>","DOI":"10.3390\/nu17132145","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T06:18:36Z","timestamp":1751264316000},"page":"2145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Association Between Prevotella copri and Advanced Fibrosis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.3390","volume":"17","author":[{"given":"David","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelaine","family":"Leitman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simer","family":"Shera","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Goodman-Luskin Microbiome Center, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-0254","authenticated-orcid":false,"given":"Jonathan P.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Goodman-Luskin Microbiome Center, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-8063","authenticated-orcid":false,"given":"Tien S.","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, CA 90095, USA"},{"name":"Goodman-Luskin Microbiome Center, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1053\/j.gastro.2021.12.288","article-title":"Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease","volume":"162","author":"Abraham","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"G473","DOI":"10.1152\/ajpgi.00271.2021","article-title":"Revisiting the gut-liver axis: Gut lymphatic system in liver cirrhosis and portal hypertension","volume":"322","author":"Juneja","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.1239275","article-title":"A gut lipid messenger links excess dietary fat to dopamine deficiency","volume":"341","author":"Tellez","year":"2013","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","article-title":"The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut","volume":"585","author":"Teratani","year":"2020","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., and Liu, Y. (2015). Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep., 5.","DOI":"10.1038\/srep08096"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lanthier, N., and Delzenne, N. (2022). Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?. Cells, 11.","DOI":"10.3390\/cells11172718"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.28860","article-title":"Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood","volume":"65","author":"Decaris","year":"2017","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0035-1550065","article-title":"Fibrosis in nonalcoholic Fatty liver disease: Mechanisms and clinical implications","volume":"35","author":"Angulo","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dong, T.S., Katzka, W., Lagishetty, V., Luu, K., Hauer, M., Pisegna, J., and Jacobs, J.P. (2020). A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-59535-w"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Estaki, M., Jiang, L., Bokulich, N.A., McDonald, D., Gonzalez, A., Kosciolek, T., Martino, C., Zhu, Q., Birmingham, A., and Vazquez-Baeza, Y. (2020). QIIME 2 Enables Comprehensive End-to-End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available Data. Curr. Protoc. Bioinform., 70.","DOI":"10.1002\/cpbi.100"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2304157","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: The role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"Cubero","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2149641","DOI":"10.1002\/eji.202149641","article-title":"The \u201cDomino effect\u201d in MASLD: The inflammatory cascade of steatohepatitis","volume":"54","author":"Mladenic","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/1389450116666150531153627","article-title":"IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression","volume":"16","author":"Giles","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2249152","DOI":"10.1080\/19490976.2023.2249152","article-title":"The curious case of Prevotella copri","volume":"15","author":"Abdelsalam","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yuan, H., Wu, X., Wang, X., Zhou, J.Y., and Park, S. (2024). Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042183"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jgh.16147","article-title":"A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesity","volume":"38","author":"Torres","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, C., Fang, S., Wei, H., He, M., Fu, H., Xiong, X., Zhou, Y., Wu, J., Gao, J., and Yang, H. (2021). Prevotella copri increases fat accumulation in pigs fed with formula diets. Microbiome, 9.","DOI":"10.1186\/s40168-021-01110-0"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2340487","DOI":"10.1080\/19490976.2024.2340487","article-title":"Effects of Prevotella copri on insulin, gut microbiota and bile acids","volume":"16","author":"Gong","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12760","article-title":"The immune response to Prevotella bacteria in chronic inflammatory disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"eLife"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.39783","article-title":"Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine","volume":"68","author":"Maeda","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice","volume":"49","author":"Minehira","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Syed-Abdul, M.M. (2023). Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). Metabolites, 14.","DOI":"10.3390\/metabo14010012"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","article-title":"Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)","volume":"1864","author":"Schreiber","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Vallianou, N.G., Kounatidis, D., Psallida, S., Vythoulkas-Biotis, N., Adamou, A., Zachariadou, T., Kargioti, S., Karampela, I., and Dalamaga, M. (2024). NAFLD\/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options. Metabolites, 14.","DOI":"10.3390\/metabo14070366"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"DiGuilio, K.M., Del Rio, E.A., Harty, R.N., and Mullin, J.M. (2024). Micronutrients at Supplemental Levels, Tight Junctions and Epithelial Barrier Function: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063452"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Paradis, T., Begue, H., Basmaciyan, L., Dalle, F., and Bon, F. (2021). Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052506"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2077620","DOI":"10.1080\/21688370.2022.2077620","article-title":"Tight junctions: From molecules to gastrointestinal diseases","volume":"11","author":"Moonwiriyakit","year":"2023","journal-title":"Tissue Barriers"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Leitman, M., Zhang, D., Pawar, S., Shera, S., Hernandez, L., Jacobs, J.P., and Dong, T.S. (2024). The Association Between Prevotella copri and Advanced Fibrosis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. bioRxiv.","DOI":"10.1101\/2024.11.22.624957"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/13\/2145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:00:28Z","timestamp":1760032828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/13\/2145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":44,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["nu17132145"],"URL":"https:\/\/doi.org\/10.3390\/nu17132145","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}